116 related articles for article (PubMed ID: 7581257)
1. Structure-activity correlationship and strain specificity of polyoxometalates in anti-human immunodeficiency virus activity.
Inouye Y; Fujimoto Y; Sugiyama M; Yoshida T; Yamase T
Biol Pharm Bull; 1995 Jul; 18(7):996-1000. PubMed ID: 7581257
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase.
Inouye Y; Tokutake Y; Kunihara J; Yoshida T; Yamase T; Nakata A; Nakamura S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):805-7. PubMed ID: 1377101
[TBL] [Abstract][Full Text] [Related]
3. Novel assay system favorable for the study of cell-to-cell transmission of HIV-1 and its application to the evaluation of anti-HIV drugs.
Inouye Y; Kanamori T; Fujimoto Y; Sugiyama M; Yoshida T
Biol Pharm Bull; 1995 Jun; 18(6):920-2. PubMed ID: 7550135
[TBL] [Abstract][Full Text] [Related]
4. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.
Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates.
Hill CL; Weeks MS; Schinazi RF
J Med Chem; 1990 Oct; 33(10):2767-72. PubMed ID: 2213829
[TBL] [Abstract][Full Text] [Related]
6. Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates.
Shigeta S; Mori S; Kodama E; Kodama J; Takahashi K; Yamase T
Antiviral Res; 2003 May; 58(3):265-71. PubMed ID: 12767474
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proliferation of human immunodeficiency virus type 1 by novel heteropolyoxotungstates in vitro.
Take Y; Tokutake Y; Inouye Y; Yoshida T; Yamamoto A; Yamase T; Nakamura S
Antiviral Res; 1991 Feb; 15(2):113-24. PubMed ID: 1859202
[TBL] [Abstract][Full Text] [Related]
8. In vitro antiviral activity of polyoxomolybdates. Mechanism of inhibitory effect of PM-104 (NH4)12H2(Eu4(MoO4)(H2O)16(Mo7O24)4).13H2O on human immunodeficiency virus type 1.
Inouye Y; Tokutake Y; Yoshida T; Seto Y; Hujita H; Dan K; Yamamoto A; Nishiya S; Yamase T; Nakamura S
Antiviral Res; 1993 Apr; 20(4):317-31. PubMed ID: 8387260
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
10. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
Witvrouw M; Weigold H; Pannecouque C; Schols D; De Clercq E; Holan G
J Med Chem; 2000 Mar; 43(5):778-83. PubMed ID: 10715146
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and beta-lactamase against methicillin-resistant Staphylococcus aureus.
Fukuda N; Yamase T; Tajima Y
Biol Pharm Bull; 1999 May; 22(5):463-70. PubMed ID: 10375165
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of highly negative charged polyoxotungstates, K27[KAs4W40O140] and K18[KSb9W21O86], and Keggin-structural polyoxotungstates against Helicobacter pylori.
Inoue M; Segawa K; Matsunaga S; Matsumoto N; Oda M; Yamase T
J Inorg Biochem; 2005 May; 99(5):1023-31. PubMed ID: 15833325
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate.
Wang X; Wang J; Zhang W; Li B; Zhu Y; Hu Q; Yang Y; Zhang X; Yan H; Zeng Y
Viruses; 2018 May; 10(5):. PubMed ID: 29772712
[TBL] [Abstract][Full Text] [Related]
14. A combination of lacunary polyoxometalates and high-nuclear transition-metal clusters under hydrothermal conditions. Part II: From double cluster, dimer, and tetramer to three-dimensional frameworks.
Zhao JW; Jia HP; Zhang J; Zheng ST; Yang GY
Chemistry; 2007; 13(36):10030-45. PubMed ID: 18038377
[TBL] [Abstract][Full Text] [Related]
15. Compounds of Mo, V and W in biochemistry and their biomedical activity.
Jelikić-Stankov M; Uskoković-Marković S; Holclajtner-Antunović I; Todorović M; Djurdjević P
J Trace Elem Med Biol; 2007; 21(1):8-16. PubMed ID: 17317520
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of metal complexation and dimerization to the chemotherapeutic potential of bicyclen-Zn2II complex against human immunodeficiency virus.
Inouye Y; Kanamori T; Yoshida T; Koike T; Shionoya M; Fujioka H; Kimura E
Biol Pharm Bull; 1996 Mar; 19(3):456-8. PubMed ID: 8924918
[TBL] [Abstract][Full Text] [Related]
18. Lignified materials as medicinal resources. V. Anti-HIV (human immunodeficiency virus) activity of some synthetic lignins.
Nakashima H; Murakami T; Yamamoto N; Naoe T; Kawazoe Y; Konno K; Sakagami H
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2102-5. PubMed ID: 1423763
[TBL] [Abstract][Full Text] [Related]
19. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production.
Shoji S; Furuishi K; Misumi S; Miyazaki T; Kino M; Yamataka K
Biochem Biophys Res Commun; 1994 Nov; 205(1):967-75. PubMed ID: 7999140
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus proliferation by macrocyclic polyamines and their metal complexes.
Inouye Y; Kanamori T; Yoshida T; Bu X; Shionoya M; Koike T; Kimura E
Biol Pharm Bull; 1994 Feb; 17(2):243-50. PubMed ID: 7515743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
